No correlation between pretreatment serum CEA levels and tumor volume in locally advanced rectal cancer patients

Clinica Chimica Acta

Volumn 413, Issue 3-4, 2012, Pages 511-515

  Kim, Yeon Joo ^a   Park, Sung Chan ^a   Kim, Dae Yong ^a   Moon, Sung Ho ^a   Chang, Hee Jin ^a   Park, Ji Won ^a   Oh, Jae Hwan ^a   Kim, Min Ju ^a   Kim, Tae Hyun ^a  

^a National Cancer Center   (South Korea)

Author keywords

CEA; Rectal cancer; Tumor volume

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ADULT; ADVANCED CANCER; AGED; ANTIGEN DETECTION; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE; OVERALL SURVIVAL; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; RECTUM CANCER; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME; VOLUMETRY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOEMBRYONIC ANTIGEN; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; TUMOR BURDEN;

EID: 84355166379     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2011.11.019     Document Type: Article

References (21)

1. Park J.W., Lim S.-B., Kim D.Y., et al. Carcinoembryonic antigen as a predictor of pathologic response and a prognostic factor in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy and surgery. Int J Radiat Oncol Biol Phys 2009, 74:810-817.
2. Kim C.W., Yu C.S., Yang S.S., et al. Clinical significance of pre- to post-chemoradiotherapy s-CEA reduction ratio in rectal cancer patients treated with preoperative chemoradiotherapy and curative resection. Ann Surg Oncol 2011.
3. Jang N.Y., Kang S.B., Kim D.W., et al. The role of carcinoembryonic antigen after neoadjuvant chemoradiotherapy in patients with rectal cancer. Dis Colon Rectum 2011, 54:245-252.
4. Park Y.A., Lee K.Y., Kim N.K., Baik S.H., Sohn S.K., Cho C.W. Prognostic effect of perioperative change of serum carcinoembryonic antigen level: a useful tool for detection of systemic recurrence in rectal cancer. Ann Surg Oncol 2006, 13:645-650.
5. Graham R.A., Wang S., Catalano P.J., Haller D.G. Postsurgical surveillance of colon cancer: preliminary cost analysis of physician examination, carcinoembryonic antigen testing, chest x-ray, and colonoscopy. Ann Surg 1998, 228:59-63.
6. Mayr N.A., Magnotta V.A., Ehrhardt J.C., et al. Usefulness of tumor volumetry by magnetic resonance imaging in assessing response to radiation therapy in carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1996, 35:915-924.
7. Mayr N.A., Yuh W.T., Zheng J., et al. Tumor size evaluated by pelvic examination compared with 3-D quantitative analysis in the prediction of outcome for cervical cancer. Int J Radiat Oncol Biol Phys 1997, 39:395-404.
8. Brown G., Richards C.J., Newcombe R.G., et al. Rectal carcinoma: thin-section MR imaging for staging in 28 patients. Radiology 1999, 211:215-222.
9. Fuchsjager M.H., Maier A.G., Schima W., et al. Comparison of transrectal sonography and double-contrast MR imaging when staging rectal cancer. AJR Am J Roentgenol 2003, 181:421-427.
10. Kim D.Y., Jung K.H., Kim T.H., et al. Comparison of 5-fluorouracil/leucovorin and capecitabine in preoperative chemoradiotherapy for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2007, 67:378-384.
11. Kim Y.H., Kim D.Y., Kim T.H., et al. Usefulness of magnetic resonance volumetric evaluation in predicting response to preoperative concurrent chemoradiotherapy in patients with resectable rectal cancer. Int J Radiat Oncol Biol Phys 2005, 62:761-768.
12. Kim T.H., Chang H.J., Kim D.Y., et al. Pathologic nodal classification is the most discriminating prognostic factor for disease-free survival in rectal cancer patients treated with preoperative chemoradiotherapy and curative resection. Int J Radiat Oncol Biol Phys 2010, 77:1158-1165.
13. Kim J.H., Beets G.L., Kim M.J., Kessels A.G., Beets-Tan R.G. High-resolution MR imaging for nodal staging in rectal cancer: are there any criteria in addition to the size?. Eur J Radiol 2004, 52:78-83.
14. Youden W.J. Index for rating diagnostic tests. Cancer 1950, 3:32-35.
15. Chung J.K., Jang J.J., Lee D.S., Lee M.C., Koh C.S. Tumor concentration and distribution of carcinoembryonic antigen measured by in vitro quantitative autoradiography. J Nucl Med 1994, 35:1499-1505.
16. Schmitz R., Nikolaizik W., Izbicki J.R., Dralle H., Pichlmayr R. Tumor volume correlated serum CEA levels in nude mice after primary xenotransplantation of human colorectal carcinoma. Cancer Detect Prev 1982, 5:325-329.
17. Compton C.C., Fielding L.P., Burgart L.J., et al. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 2000, 124:979-994.
18. Nielsen M.B., Qvitzau S., Pedersen J.F. Detection of pericolonic lymph nodes in patients with colorectal cancer: an in vitro and in vivo study of the efficacy of endosonography. AJR Am J Roentgenol 1993, 161:57-60.
19. Zerhouni E.A., Rutter C., Hamilton S.R., et al. CT and MR imaging in the staging of colorectal carcinoma: report of the Radiology Diagnostic Oncology Group II. Radiology 1996, 200:443-451.
20. Beets-Tan R.G., Beets G.L. Rectal cancer: review with emphasis on MR imaging. Radiology 2004, 232:335-346.
21. Choi M.Y., Lee K.M., Chung J.K., et al. Correlateion between serum CEA level and metabolic volume as determined by PET in postoperative patients with recurrence colorectal cancer. Ann Nucl Med 2005, 19(2):123-129.